000153 丰原药业
已收盘 12-18 15:00:00
资讯
新帖
简况
丰原药业（000153）股东蚌埠涂山企业管理有限公司质押3236万股，占总股本6.96%
证券之星 · 12-09
丰原药业（000153）股东蚌埠涂山企业管理有限公司质押3236万股，占总股本6.96%
丰原药业（000153）2名股东合计质押4574万股，占总股本9.84%
证券之星 · 11-26
丰原药业（000153）2名股东合计质押4574万股，占总股本9.84%
股市必读：丰原药业（000153）11月18日董秘有最新回复
证券之星 · 11-20
股市必读：丰原药业（000153）11月18日董秘有最新回复
每周股票复盘：丰原药业（000153）拟回购注销88,200股
证券之星 · 11-16
每周股票复盘：丰原药业（000153）拟回购注销88,200股
丰原药业（000153）披露回购注销部分限制性股票减资暨通知债权人公告，11月11日股价上涨0.29%
证券之星 · 11-11
丰原药业（000153）披露回购注销部分限制性股票减资暨通知债权人公告，11月11日股价上涨0.29%
每周股票复盘：丰原药业（000153）824.25万股将上市流通
证券之星 · 11-02
每周股票复盘：丰原药业（000153）824.25万股将上市流通
丰原药业（000153）披露股东进行约定购回式证券交易暨持股比例变动超过1%的公告，10月31日股价上涨1.68%
证券之星 · 10-31
丰原药业（000153）披露股东进行约定购回式证券交易暨持股比例变动超过1%的公告，10月31日股价上涨1.68%
丰原药业（000153）披露2022年限制性股票激励计划第三个解除限售期解除限售股份上市流通提示性公告，10月29日股价下跌1.05%
证券之星 · 10-29
丰原药业（000153）披露2022年限制性股票激励计划第三个解除限售期解除限售股份上市流通提示性公告，10月29日股价下跌1.05%
股市必读：丰原药业（000153）10月28日董秘有最新回复
证券之星 · 10-29
股市必读：丰原药业（000153）10月28日董秘有最新回复
丰原药业（000153）2025年三季报简析：净利润同比下降31.92%
证券之星 · 10-25
丰原药业（000153）2025年三季报简析：净利润同比下降31.92%
丰原药业(000153.SZ)发布前三季度业绩，归母净利润1亿元，同比下降31.92%
智通财经 · 10-23
丰原药业(000153.SZ)发布前三季度业绩，归母净利润1亿元，同比下降31.92%
股市必读：丰原药业（000153）10月21日董秘有最新回复
证券之星 · 10-22
股市必读：丰原药业（000153）10月21日董秘有最新回复
丰原药业：近两年未有产品出口至欧盟国家
证券之星 · 10-21
丰原药业：近两年未有产品出口至欧盟国家
每周股票复盘：丰原药业（000153）丰原集团转让5.1%股份完成过户
证券之星 · 09-07
每周股票复盘：丰原药业（000153）丰原集团转让5.1%股份完成过户
丰原药业收盘上涨1.04%，滚动市盈率23.12倍，总市值31.65亿元
金融界 · 09-01
丰原药业收盘上涨1.04%，滚动市盈率23.12倍，总市值31.65亿元
每周股票复盘：丰原药业（000153）股东户数减少，业绩下滑
证券之星 · 08-24
每周股票复盘：丰原药业（000153）股东户数减少，业绩下滑
图解丰原药业中报：第二季度单季净利润同比下降28.09%
证券之星 · 08-21
图解丰原药业中报：第二季度单季净利润同比下降28.09%
每周股票复盘：丰原药业（000153）控股股东拟协议转让5.10%股份
证券之星 · 08-17
每周股票复盘：丰原药业（000153）控股股东拟协议转让5.10%股份
丰原药业最新公告：丰原集团、马鞍山丰原合计将其持有的公司2369.86万股转让给贵和达毅
证券之星 · 08-11
丰原药业最新公告：丰原集团、马鞍山丰原合计将其持有的公司2369.86万股转让给贵和达毅
肝素概念盘中拉升，丰原药业涨停
市场透视 · 07-28
肝素概念盘中拉升，丰原药业涨停
加载更多
公司概况
公司名称：
安徽丰原药业股份有限公司
所属行业：
医药制造业
上市日期：
2000-09-20
主营业务：
安徽丰原药业股份有限公司的主营业务是医药制造和商业流通。公司的主要产品是生物药及制剂、化学合成药及制剂、药用辅料、中药及制剂、药品零售、药品批发。
发行价格：
18.80
{"stockData":{"symbol":"000153","market":"SZ","secType":"STK","nameCN":"丰原药业","latestPrice":6.4,"timestamp":1766041401000,"preClose":6.28,"halted":0,"volume":8185860,"delay":0,"changeRate":0.0191,"floatShares":461000000,"shares":465000000,"eps":0.2449,"marketStatus":"已收盘","change":0.12,"latestTime":"12-18 15:00:00","open":6.26,"high":6.43,"low":6.24,"amount":52245100,"amplitude":0.0303,"askPrice":6.41,"askSize":655,"bidPrice":6.4,"bidSize":1284,"shortable":0,"etf":0,"ttmEps":0.2449,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766107800000},"marketStatusCode":5,"adr":0,"adjPreClose":6.28,"symbolType":"stock","openAndCloseTimeList":[[1766021400000,1766028600000],[1766034000000,1766041200000]],"highLimit":6.91,"lowLimit":5.65,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":464773722,"isCdr":false,"pbRate":1.39,"roa":"--","peRate":26.133116,"roe":"4.85%","epsLYR":0.3461,"committee":-0.34513,"marketValue":2975000000,"turnoverRate":0.0178,"status":0,"floatMarketCap":2948000000},"requestUrl":"/m/hq/s/000153","defaultTab":"news","newsList":[{"id":"2590317081","title":"丰原药业（000153）股东蚌埠涂山企业管理有限公司质押3236万股，占总股本6.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590317081","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590317081?lang=zh_cn&edition=full","pubTime":"2025-12-09 18:41","pubTimestamp":1765276900,"startTime":"0","endTime":"0","summary":"证券之星消息，丰原药业12月9日公开信息显示，股东蚌埠涂山企业管理有限公司向山东省国际信托股份有限公司合计质押3236.0万股，占总股本6.96%。质押详情见下表：截止本公告日，股东安徽省无为制药厂已累计质押股份3162.0万股，占其持股总数的63.01%，股东蚌埠涂山企业管理有限公司已累计质押股份3236.0万股，占其持股总数的90.57%，股东马鞍山丰原企业管理有限公司已累计质押股份1412.0万股，占其持股总数的60.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900030110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000153","BK0060"],"gpt_icon":0},{"id":"2586255147","title":"丰原药业（000153）2名股东合计质押4574万股，占总股本9.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586255147","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586255147?lang=zh_cn&edition=full","pubTime":"2025-11-26 18:40","pubTimestamp":1764153652,"startTime":"0","endTime":"0","summary":"证券之星消息，丰原药业11月26日公开信息显示，股东安徽省无为制药厂、马鞍山丰原企业管理有限公司向山东省国际信托股份有限公司合计质押4574.0万股，占总股本9.84%。质押详情见下表：截止本公告日，股东安徽省无为制药厂已累计质押股份3162.0万股，占其持股总数的63.01%，股东马鞍山丰原企业管理有限公司已累计质押股份1412.0万股，占其持股总数的60.43%。丰原药业主营业务：主要业务包括医药制造和商业流通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600029061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0239","BK0060"],"gpt_icon":0},{"id":"2584392127","title":"股市必读：丰原药业（000153）11月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584392127","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584392127?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:05","pubTimestamp":1763571917,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，丰原药业报收于6.93元，下跌0.57%，换手率2.03%，成交量9.36万手，成交额6496.58万元。董秘最新回复投资者： 请问公司截至10月31日的股东人数是多少，谢谢董秘： 您好，公司将在定期报告中披露对应时点的股东人数，敬请关注公司后续披露的定期报告。当日关注点来自交易信息汇总：11月18日主力资金净流出1118.76万元，占总成交额17.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000000459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0060","BK0239"],"gpt_icon":0},{"id":"2583514836","title":"每周股票复盘：丰原药业（000153）拟回购注销88,200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583514836","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583514836?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:45","pubTimestamp":1763235917,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，丰原药业报收于7.03元，较上周的6.79元上涨3.53%。本周关注点公司公告汇总：丰原药业拟回购注销88,200股限制性股票，注册资本将相应减少。关于回购注销部分限制性股票减资暨通知债权人公告指出，公司于2025年10月22日召开第十届董事会第三次会议，审议通过回购注销3名激励对象已获授但尚未解除限售的88,200股限制性股票。该事项已于2025年11月11日经2025年第二次临时股东会批准。本次回购注销将导致公司注册资本减少88,200元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0060","BK0239"],"gpt_icon":0},{"id":"2582367583","title":"丰原药业（000153）披露回购注销部分限制性股票减资暨通知债权人公告，11月11日股价上涨0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582367583","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582367583?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:24","pubTimestamp":1762871066,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，丰原药业报收于6.92元，较前一交易日上涨0.29%，最新总市值为32.16亿元。公司近日发布公告称，安徽丰原药业股份有限公司于2025年10月22日召开第十届董事会第三次会议，审议通过《关于回购注销部分限制性股票的议案》，同意回购注销3名激励对象已获授但尚未解除限售的88,200股限制性股票。该事项已于2025年11月11日经公司2025年第二次临时股东会审议通过。本次回购注销将导致公司注册资本减少88,200元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100040884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0239","BK0060"],"gpt_icon":0},{"id":"2580688403","title":"每周股票复盘：丰原药业（000153）824.25万股将上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2580688403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580688403?lang=zh_cn&edition=full","pubTime":"2025-11-02 09:32","pubTimestamp":1762047132,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，丰原药业报收于6.65元，较上周的6.69元下跌0.6%。公司公告汇总安徽丰原药业股份有限公司发布关于2022年限制性股票激励计划第三个解除限售期解除限售股份上市流通的提示性公告：本次解除限售数量为8,242,500股，占公司总股本的1.7734%。本次解除限售后，公司限售股减少8,242,500股，无限售条件流通股相应增加，总股本不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000153","BK0239"],"gpt_icon":0},{"id":"2579457238","title":"丰原药业（000153）披露股东进行约定购回式证券交易暨持股比例变动超过1%的公告，10月31日股价上涨1.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579457238","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579457238?lang=zh_cn&edition=full","pubTime":"2025-10-31 18:26","pubTimestamp":1761906383,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，丰原药业报收于6.65元，较前一交易日上涨1.68%，最新总市值为30.91亿元。近日，丰原药业发布关于股东进行约定购回式证券交易暨持股比例变动超过1%的公告。公告显示，公司股东马鞍山丰原企业管理有限公司于2025年10月30日将其持有的924万股无限售流通股在国元证券股份有限公司办理了约定购回式证券交易，购回期限至2026年10月28日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100039815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000153"],"gpt_icon":0},{"id":"2579976000","title":"丰原药业（000153）披露2022年限制性股票激励计划第三个解除限售期解除限售股份上市流通提示性公告，10月29日股价下跌1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579976000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579976000?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:26","pubTimestamp":1761733583,"startTime":"0","endTime":"0","summary":"公司近日发布公告，就2022年限制性股票激励计划第三个解除限售期解除限售股份上市流通事项作出提示。根据公告，本次解除限售数量为8,242,500股，占公司总股本的1.7734%。可上市流通日为2025年11月3日。公司于2025年10月22日召开董事会及监事会，审议通过相关议案，确认第三个解除限售期解除限售条件已成就。本次解除限售后，公司限售条件流通股减少8,242,500股，无限售条件流通股相应增加，总股本不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000153","BK0239"],"gpt_icon":0},{"id":"2579911875","title":"股市必读：丰原药业（000153）10月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2579911875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579911875?lang=zh_cn&edition=full","pubTime":"2025-10-29 07:30","pubTimestamp":1761694241,"startTime":"0","endTime":"0","summary":"公司公告汇总关于2022年限制性股票激励计划第三个解除限售期解除限售股份上市流通的提示性公告安徽丰原药业股份有限公司关于2022年限制性股票激励计划第三个解除限售期解除限售股份上市流通的提示性公告：本次解除限售数量为8,242,500股，占公司总股本的1.7734%。可上市流通日为2025年11月3日。公司于2025年10月22日召开董事会及监事会，审议通过相关议案，确认第三个解除限售期解除限售条件已成就。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900011464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","000153"],"gpt_icon":0},{"id":"2578252545","title":"丰原药业（000153）2025年三季报简析：净利润同比下降31.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578252545","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578252545?lang=zh_cn&edition=full","pubTime":"2025-10-25 06:05","pubTimestamp":1761343502,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期丰原药业发布2025年三季报。根据财报显示，丰原药业净利润同比下降31.92%。截至本报告期末，公司营业总收入31.25亿元，同比下降4.18%，归母净利润1.0亿元，同比下降31.92%。按单季度数据看，第三季度营业总收入10.98亿元，同比上升15.15%，第三季度归母净利润2400.58万元，同比下降49.02%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102500005487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153"],"gpt_icon":0},{"id":"2577686300","title":"丰原药业(000153.SZ)发布前三季度业绩，归母净利润1亿元，同比下降31.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577686300","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577686300?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:33","pubTimestamp":1761226410,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丰原药业(000153.SZ)发布2025年三季度报告，前三季度，公司实现营业收入31.25亿元，同比下降4.18%。归属于上市公司股东的净利润1亿元，同比下降31.92%。归属于上市公司股东的扣除非经常性损益的净利润7491.51万元，同比下降36.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"丰原药业(000153.SZ)发布前三季度业绩，归母净利润1亿元，同比下降31.92%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000153"],"gpt_icon":0},{"id":"2577098988","title":"股市必读：丰原药业（000153）10月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577098988","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577098988?lang=zh_cn&edition=full","pubTime":"2025-10-22 03:06","pubTimestamp":1761073574,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，丰原药业报收于6.74元，上涨1.51%，换手率1.89%，成交量8.54万手，成交额5725.13万元。董秘最新回复投资者： 请问贵公司近两年是否出口至欧盟国家？当日关注点来自交易信息汇总：10月21日主力资金净流出556.2万元，占总成交额9.72%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200002308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","000153"],"gpt_icon":0},{"id":"2577847422","title":"丰原药业：近两年未有产品出口至欧盟国家","url":"https://stock-news.laohu8.com/highlight/detail?id=2577847422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577847422?lang=zh_cn&edition=full","pubTime":"2025-10-21 16:42","pubTimestamp":1761036140,"startTime":"0","endTime":"0","summary":"证券之星消息，丰原药业(000153)10月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司近两年是否出口至欧盟国家？丰原药业回复：您好，公司近两年未有产品出口至欧盟国家。感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100024588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FSXEmain","BK0060","000153","FESXmain","BK0239"],"gpt_icon":0},{"id":"2565546561","title":"每周股票复盘：丰原药业（000153）丰原集团转让5.1%股份完成过户","url":"https://stock-news.laohu8.com/highlight/detail?id=2565546561","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565546561?lang=zh_cn&edition=full","pubTime":"2025-09-07 07:24","pubTimestamp":1757201058,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，丰原药业报收于6.76元，较上周的6.74元上涨0.3%。本周关注点公司公告汇总：丰原集团及其一致行动人向贵和达毅转让5.1%股份已完成过户。公司公告汇总安徽丰原药业股份有限公司于2025年9月3日公告，控股股东安徽丰原集团有限公司及其一致行动人马鞍山丰原企业管理有限公司向海南贵和达毅投资合伙企业协议转让公司部分股份已完成过户登记。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000153"],"gpt_icon":0},{"id":"2564897392","title":"丰原药业收盘上涨1.04%，滚动市盈率23.12倍，总市值31.65亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564897392","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564897392?lang=zh_cn&edition=full","pubTime":"2025-09-01 16:08","pubTimestamp":1756714102,"startTime":"0","endTime":"0","summary":"9月1日，丰原药业今日收盘6.81元，上涨1.04%，滚动市盈率PE达到23.12倍，总市值31.65亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均63.54倍，行业中值37.09倍，丰原药业排名第59位。资金流向方面，9月1日，丰原药业主力资金净流入413.91万元，近5日总体呈流出状态，5日共流出5529.20万元。安徽丰原药业股份有限公司的主营业务是医药制造和商业流通。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/01160852845272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","000153","BK0060"],"gpt_icon":0},{"id":"2561253249","title":"每周股票复盘：丰原药业（000153）股东户数减少，业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2561253249","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561253249?lang=zh_cn&edition=full","pubTime":"2025-08-24 06:26","pubTimestamp":1755987977,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，丰原药业报收于7.06元，较上周的7.01元上涨0.71%。本周，丰原药业8月19日盘中最高价报7.27元。本周关注点股本股东变化：截至2025年6月30日公司股东户数为3.43万户，较3月31日减少1123.0户业绩披露要点：2025年中报显示，公司主营收入20.27亿元，同比下降12.16%股本股东变化近日丰原药业披露，截至2025年6月30日公司股东户数为3.43万户，较3月31日减少1123.0户，减幅为3.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400001889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000153"],"gpt_icon":0},{"id":"2561465876","title":"图解丰原药业中报：第二季度单季净利润同比下降28.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561465876","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561465876?lang=zh_cn&edition=full","pubTime":"2025-08-21 17:48","pubTimestamp":1755769700,"startTime":"0","endTime":"0","summary":"证券之星消息，丰原药业2025年中报显示，公司主营收入20.27亿元，同比下降12.16%；归母净利润7627.85万元，同比下降23.88%；扣非净利润6052.62万元，同比下降29.32%；其中2025年第二季度，公司单季度主营收入10.86亿元，同比下降8.49%；单季度归母净利润3825.77万元，同比下降28.09%；单季度扣非净利润2699.89万元，同比下降38.59%；负债率56.21%，投资收益-0.06万元，财务费用1427.26万元，毛利率19.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100030193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153"],"gpt_icon":0},{"id":"2560925234","title":"每周股票复盘：丰原药业（000153）控股股东拟协议转让5.10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2560925234","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560925234?lang=zh_cn&edition=full","pubTime":"2025-08-17 03:42","pubTimestamp":1755373333,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘，丰原药业报收于7.01元，较上周的7.07元下跌0.85%。贵和达毅承诺过户登记手续完成后的十八个月内不减持本次协议转让所受让的公司股份。变动后，丰原集团及其一致行动人合计持有公司股份109,277,121股，占总股本23.51%。贵和达毅在本次变动前未持有丰原药业股份，且在未来12个月内无继续增持计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000153","BK0060","BK0239"],"gpt_icon":0},{"id":"2558663600","title":"丰原药业最新公告：丰原集团、马鞍山丰原合计将其持有的公司2369.86万股转让给贵和达毅","url":"https://stock-news.laohu8.com/highlight/detail?id=2558663600","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558663600?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:01","pubTimestamp":1754917272,"startTime":"0","endTime":"0","summary":"丰原药业(000153.SZ)公告称，公司控股股东安徽丰原集团有限公司及其一致行动人马鞍山丰原企业管理有限公司拟通过协议转让方式，向海南贵和达毅投资合伙企业（有限合伙）转让其持有的公司股份合计23,698,554股，占公司总股本的5.10%。本次交易不涉及要约收购，不涉及关联交易，不会导致公司控制权发生变化，不会对公司治理结构及持续经营产生重大影响。转让价格为6.72元/股，股份转让总价款合计为人民币1.59亿元。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081100037371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000153","BK0060"],"gpt_icon":0},{"id":"2554699744","title":"肝素概念盘中拉升，丰原药业涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2554699744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554699744?lang=zh_cn&edition=full","pubTime":"2025-07-28 09:44","pubTimestamp":1753667098,"startTime":"0","endTime":"0","summary":"07月28日，肝素概念盘中拉升，截至09点44分，肝素概念整体指数上涨1.01%，报1115.560点。从个股上来看，该概念的成分股中，丰原药业涨停，辰欣药业、红日药业、赛升药业涨幅居前。从资金上来看，截止发稿，肝素概念主力净流入为2596.68万，其中丰原药业受到资金热捧，主力净流入4404.83万；拉长时间线来看，该板块近20日主力资金净流入-35.34亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728094458a466a03e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728094458a466a03e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603367","000153","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766060243922,"stockEarnings":[{"period":"1week","weight":-0.0427},{"period":"1month","weight":-0.099},{"period":"3month","weight":-0.0556},{"period":"6month","weight":0.0644},{"period":"1year","weight":-0.0178},{"period":"ytd","weight":0.0415}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0256},{"period":"3month","weight":0.0101},{"period":"6month","weight":0.1519},{"period":"1year","weight":0.1514},{"period":"ytd","weight":0.1547}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽丰原药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"39078人(较上一季度增加13.90%)","perCapita":"11785股","listingDate":"2000-09-20","address":"安徽省芜湖市无为市通江大道188号","registeredCapital":"46477万元","survey":" 安徽丰原药业股份有限公司的主营业务是医药制造和商业流通。公司的主要产品是生物药及制剂、化学合成药及制剂、药用辅料、中药及制剂、药品零售、药品批发。","listedPrice":18.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丰原药业(000153)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丰原药业(000153)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丰原药业,000153,丰原药业股票,丰原药业股票老虎,丰原药业股票老虎国际,丰原药业行情,丰原药业股票行情,丰原药业股价,丰原药业股市,丰原药业股票价格,丰原药业股票交易,丰原药业股票购买,丰原药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丰原药业(000153)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丰原药业(000153)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}